STRATEGIC ADVISORY & HANDS-ON EXECUTION
From Vision
To Adoption
We partner with medtech companies to define and execute product, clinical, and commercial strategies that build enterprise value. Our work pairs strategic judgment with hands-on execution across product definition, clinical evidence generation, and commercialization.
FRACTIONAL EXECUTION FOR MEDTECH GROWTH
Services
Product Definition
Identify high-value market opportunities and the pathway to commercial adoption. We partner with you to build a robust product roadmap informed by user insights, market intelligence, and health economics to align your core innovations with market needs.
Clinical Execution
Design and run first-in-human and pivotal trials that generate compelling evidence. We help you develop trial strategies and protocols, recruit high-quality sites, and provide clinician training and on-site case support to achieve your clinical objectives.
Commercialization
Translate your technological and clinical differentiators into compelling market messaging. We create the frameworks and content needed to educate investors and customers and drive commercial adoption.
Ben Hu
Principal & Founder
Ben delivers strategic business advisory and fractional execution services to medtech startups and growth companies. He specializes in guiding leadership teams through the critical milestones required to advance complex projects from concept to commercialization. By optimizing product-market fit, generating compelling preclinical and clinical evidence, and translating complex data into powerful messaging, Ben helps companies secure essential fundraising and build clinician trust. His unique strength lies in bridging the gap between high-level strategy and cross-functional execution, making him an invaluable asset to organizations looking to accelerate their financing and growth.
Before founding Parallax, Ben served as the head of Product Management at Jupiter Endovascular. In this role, he directed product roadmapping for the Vertex Thrombectomy System, led the development of the Vertex clinical procedure, and co-led the successful execution of the SPIRARE I and SPIRARE II clinical trials, which directly contributed to a $40M+ Series B financing round. Prior to Jupiter, he held pivotal leadership roles across both venture-backed startups and market-leading, large-cap medtech organizations, including Stryker, Medtronic, and Neptune Medical.
Ben holds an MBA and a BSE in Mechanical Engineering from Duke University. He is deeply passionate about growing regional medtech ecosystems beyond traditional medtech hubs, actively serving as a coach and mentor with the Center for Entrepreneurial Development, First Flight Venture Center, Innovate Carolina, and the Lampe Joint Department of Biomedical Engineering.
Get In Touch
Let's discuss how we can accelerate your growth together.